International Cancer Research Conference
March 24-26, 2025 | Singapore
Cancer Management and Research
When a patient is diagnosed with cancer, they may need medical treatment and specialized care for months or years. Surgery, radiotherapy, and chemotherapy are the three main types of treatment that can be used alone or in combination. When cancer therapy isn't curative, it's critical to maintain the highest possible quality of life. Supportive and palliative care are vital for many patients, and this typically entails a wide range of professional services that go beyond oncology.
Cancer research identifies the causes of cancer and develops prevention, diagnosis, treatment, and cure strategies. Cancer research encompasses everything from epidemiology to molecular biology to the conduct of clinical studies to assess and compare the efficacy of various cancer treatments.
- Supportive and palliative care
- Cancer management during pandemic
- COVID and its impact on cancer patients
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Michael Thompson
University of Toronto, Canada
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Andrea González Báez
Autonomous University of Nuevo Leon, Mexico
Qian Zhang
The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, ChinaSubmit your abstract Today
Title :
Patricia Tai, Saskatchewan Cancer Agency, Canada
Title :
Atif A Ahmed, Seattle Children’s Hospital, United States
Title :
Marika Crohns, Sanofi, Germany
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada